NRG G0281

Primary Category:

Treatment Protocols

Disease Category:

Gynecologic, Ovarian

Status:

Closed

A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients with Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer

NCT#02101788

G0281 has met its target accrual goal in the U.S. and the study is no longer accepting any additional specimens for screening.  Closure notice to follow soon.